Skip to main content
. 2019 Nov 8;11(11):1756. doi: 10.3390/cancers11111756

Table 1.

Examples of suppressive (negative) and stimulatory (positive) immune checkpoint ligand–receptor pairs with cellular distribution of these molecules under physiological conditions.

Ligand Cellular Distribution of the Ligand Expression Immune Checkpoint Receptor Cellular Expression of the Receptor Expression
Suppressive (negative) immune checkpoints
CD80 or CD86 Antigen-presenting cells CTLA4 Activated T cells, Tregs
PD-L1 (CD274) or PD-L2 (CD273) DCs, macrophages, peripheral non-lymphoid tissues PD-1 Activated B and T cells, APCs, NK cells
MHC class II/Lectins Antigen-presenting cells LAG3 Activated T cells, Tregs, NK cells, B cells, DCs
CD155/CD112 Normal epithelial, endothelial, neuronal, and fibroblastic cells TIGIT Activated T cells, Tregs, NK cells
Galectin 9/ PtdSer /HMGB1 Multiple tissues TIM3 Activated T cells
VSIG-3 Neurons and glial cells VISTA Naïve and activated T cells
CEACAM1 T and NK cells CEACAM1 Activated T and NK cells
Stimulatory (positive) immune checkpoints
B7 molecules: CD80 or CD86 Antigen-presenting cells CD28 T cells
OX40L DCs, macrophages, B cells, endothelial cells, smooth muscle cells OX40 Activated T cells, Tregs, NK cells, neutrophils
CD137L Antigen-presenting cells CD137 (4-1BB) Activated Tcells, NK cells, B cells, DCs, endothelial cells
GITRL Antigen-presenting cells and endothelium GITR T and NK cells, Tregs
ICOSLG APCs, B cells, DCs and macrophages ICOS Naïve and activated T cells
CD70 Activated lymphocytes CD27 Activated T and NK cells